A recent GWAS demonstrated that the genetic diversity of HLA-DRB1 and HLA-DQB1 alleles modulates responses to treatment with lithium-containing drugs in bipolar affective disorders [80]. This evidence concerns the gene HLA-DQB1 and bipolar disorder.